Loading...

Annie Luetkemeyer, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-476-4082 ext. 130
ORCID ORCID Icon0000-0003-0911-1578 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco2006 Advance Training in Clinical Research
    University of California, San Francisco, SFVAMC2003Internal Medicine
    University of California, San Francisco2002Internal Medicine
    University of California, San FranciscoFellowship2007Infectious Diseases
    Harvard Medical SchoolMD1999Medicine
    Stanford UniversityAB1994American Studies

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse In The News
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020 May 22. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC. PMID: 32445440.
      View in: PubMed   Mentions: 206     Fields:    
    2. Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence. Aliment Pharmacol Ther. 2020 06; 51(12):1384-1396. Sulkowski M, Luetkemeyer AF, Wyles DL, Martorell C, Muir A, Weisberg I, Gordon SC, McLain R, Huhn G. PMID: 32352586.
      View in: PubMed   Mentions:    Fields:    
    3. Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals. Clin Infect Dis. 2019 07 18; 69(3):514-522. Naggie S, Fierer DS, Hughes MD, Kim AY, Luetkemeyer A, Vu V, Roa J, Rwema S, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Marks KM, Chung RT. PMID: 31220220.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    4. A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome. Int J Infect Dis. 2019 Jul; 84:30-38. Silva CAM, Graham B, Webb K, Ashton LV, Harton M, Luetkemeyer AF, Bokatzian S, Almubarak R, Mahapatra S, Hovind L, Kendall MA, Havlir D, Belisle JT, De Groote MA. PMID: 31009738.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Localized US Efforts to Eliminate Hepatitis C. Infect Dis Clin North Am. 2018 06; 32(2):293-311. Gaudino A, Gay B, Garmon C, Selick M, Vreeland R, Burk K, Huriaux E, Facente SN, Luetkemeyer A, Waters P, Graham CS. PMID: 29778257.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    6. Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials. Liver Int. 2018 06; 38(6):1010-1021. Tam E, Luetkemeyer AF, Mantry PS, Satapathy SK, Ghali P, Kang M, Haubrich R, Shen X, Ni L, Camus G, Copans A, Rossaro L, Guyer B, Brown RS. PMID: 29091342.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    7. Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure. Hepatology. 2017 12; 66(6):1794-1804. Wyles D, Wedemeyer H, Ben-Ari Z, Gane EJ, Hansen JB, Jacobson IM, Laursen AL, Luetkemeyer A, Nahass R, Pianko S, Zeuzem S, Jumes P, Huang HC, Butterton J, Robertson M, Wahl J, Barr E, Joeng HK, Martin E, Serfaty L. PMID: 28688129.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    8. Disabling Dactylitis and Tenosynovitis Due to Mycobacterium haemophilum in a Patient With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome. Open Forum Infect Dis. 2017; 4(3):ofx165. Woodworth MH, Marquez C, Chambers H, Luetkemeyer A. PMID: 28959701.
      View in: PubMed   Mentions:
    9. Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis. J Clin Med. 2017 Aug 07; 6(8). Badal-Faesen S, Firnhaber C, Kendall MA, Wu X, Grinsztejn B, Escada RODS, Fernandez M, Hogg E, Sanne I, Johnson P, Alland D, Mazurek GH, Benator DA, Luetkemeyer AF. PMID: 28783093.
      View in: PubMed   Mentions:
    10. Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2. Open Forum Infect Dis. 2017; 4(3):ofx154. Rockstroh JK, Orkin C, Viani RM, Wyles D, Luetkemeyer AF, Lazzarin A, Soto-Malave R, Nelson MR, Bhagani SR, Klinker HHF, Rizzardini G, Girard PM, Tural C, Shulman NS, Mobashery N, Hu YB, Fredrick LM, Pilot-Matias T, Trinh R, Gane E. PMID: 28948180.
      View in: PubMed   Mentions:
    11. Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens. Top Antivir Med. 2017 Jul/Aug; 25(3):103-109. Wyles DL, Luetkemeyer AF. PMID: 28820725.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    12. Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study. Clin Infect Dis. 2017 Jul 01; 65(1):6-12. Wyles D, Bräu N, Kottilil S, Daar ES, Ruane P, Workowski K, Luetkemeyer A, Adeyemi O, Kim AY, Doehle B, Huang KC, Mogalian E, Osinusi A, McNally J, Brainard DM, McHutchison JG, Naggie S, Sulkowski M. PMID: 28369210.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    13. CROI 2017: Highlights of Advances in Viral Hepatitis and Liver Fibrosis. Top Antivir Med. 2017 May/Jun; 25(2):84-92. Luetkemeyer AF, Wyles DL. PMID: 28598793.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    14. Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients. J Interferon Cytokine Res. 2017 03; 37(3):103-111. Nelson M, Rubio R, Lazzarin A, Romanova S, Luetkemeyer A, Conway B, Molina JM, Xu D, Srinivasan S, Portsmouth S. PMID: 28282271.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    15. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. Ann Intern Med. 2016 Nov 01; 165(9):625-634. Dore GJ, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, Luetkemeyer A, Nahass R, Peng CY, Conway B, Grebely J, Howe AY, Gendrano IN, Chen E, Huang HC, Dutko FJ, Nickle DC, Nguyen BY, Wahl J, Barr E, Robertson MN, Platt HL. PMID: 27537841.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    16. Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. PLoS One. 2016; 11(7):e0158262. Saharia KK, Petrovas C, Ferrando-Martinez S, Leal M, Luque R, Ive P, Luetkemeyer A, Havlir D, Koup RA. PMID: 27367521.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    17. A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries. BMC Infect Dis. 2016 06 10; 16:269. Godfrey C, Tauscher G, Hunsberger S, Austin M, Scott L, Schouten JT, Luetkemeyer AF, Benson C, Coombs R, Swindells S. PMID: 27287374.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    18. CROI 2016: Viral Hepatitis and Liver Fibrosis. Top Antivir Med. 2016 May-Jun; 24(1):47-58. Luetkemeyer AF, Wyles DL. PMID: 27398862.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda. Pediatr Infect Dis J. 2016 May; 35(5):524-9. Marquez C, Chamie G, Achan J, Luetkemeyer AF, Kyohere M, Okiring J, Dorsey G, Kamya MR, Charlebois ED, Havlir DV. PMID: 26771662.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    20. 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. Clin Infect Dis. 2016 06 15; 62(12):1489-96. Luetkemeyer AF, McDonald C, Ramgopal M, Noviello S, Bhore R, Ackerman P. PMID: 27025835.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    21. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clin Infect Dis. 2016 May 01; 62(9):1081-8. Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D. PMID: 26839383.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    22. The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. . 2016 Feb 01; 71(2):163-71. Jacobson JM, Zheng L, Wilson CC, Tebas P, Matining RM, Egan MA, Eldridge J, Landay AL, Clifford DB, Luetkemeyer AF, Tiu J, Martinez AL, Janik J, Spitz TA, Hural J, McElrath J, Frahm N. PMID: 26761518.
      View in: PubMed   Mentions:
    23. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med. 2015 Aug 20; 373(8):714-25. Wyles DL, Ruane PJ, Sulkowski MS, Dieterich D, Luetkemeyer A, Morgan TR, Sherman KE, Dretler R, Fishbein D, Gathe JC, Henn S, Hinestrosa F, Huynh C, McDonald C, Mills A, Overton ET, Ramgopal M, Rashbaum B, Ray G, Scarsella A, Yozviak J, McPhee F, Liu Z, Hughes E, Yin PD, Noviello S, Ackerman P. PMID: 26196502.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansCells
    24. Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med. 2015 Aug 20; 373(8):705-13. Naggie S, Cooper C, Saag M, Workowski K, Ruane P, Towner WJ, Marks K, Luetkemeyer A, Baden RP, Sax PE, Gane E, Santana-Bagur J, Stamm LM, Yang JC, German P, Dvory-Sobol H, Ni L, Pang PS, McHutchison JG, Stedman CA, Morales-Ramirez JO, Bräu N, Jayaweera D, Colson AE, Tebas P, Wong DK, Dieterich D, Sulkowski M. PMID: 26196665.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCellsCTClinical Trials
    25. Bartonella quintana Aortitis in a Man with AIDS, Diagnosed by Needle Biopsy and 16S rRNA Gene Amplification. J Clin Microbiol. 2015 Aug; 53(8):2773-6. Lee SA, Plett SK, Luetkemeyer AF, Borgo GM, Ohliger MA, Conrad MB, Cookson BT, Sengupta DJ, Koehler JE. PMID: 26063867.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    26. CROI 2015: Highlights of Viral Hepatitis Therapy. Top Antivir Med. 2015 Mar-Apr; 23(1):66-76. Luetkemeyer AF, Wyles DL. PMID: 25965313.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    27. Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study. Clin Infect Dis. 2015 Jun 15; 60(12):1860-3. Luetkemeyer AF, Rosenkranz SL, Lu D, Grinsztejn B, Sanchez J, Ssemmanda M, Sanne I, McIlleron H, Havlir DV, Haas DW. PMID: 25722197.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA. 2014 Jul 23-30; 312(4):353-61. Sulkowski MS, Naggie S, Lalezari J, Fessel WJ, Mounzer K, Shuhart M, Luetkemeyer AF, Asmuth D, Gaggar A, Ni L, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Rodriguez-Torres M, Dieterich D. PMID: 25038354.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCellsCTClinical Trials
    29. Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin. Antimicrob Agents Chemother. 2014 Sep; 58(9):5245-52. Dooley KE, Luetkemeyer AF, Park JG, Allen R, Cramer Y, Murray S, Sutherland D, Aweeka F, Koletar SL, Marzan F, Bao J, Savic R, Haas DW. PMID: 24957823.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    30. CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2014 May; 22(2):602-15. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 24901886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. HIV-associated central nervous system tuberculosis. Semin Neurol. 2014 Feb; 34(1):103-15. Chamie G, Marquez C, Luetkemeyer A. PMID: 24715493.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs. . 2014 Apr 01; 65(4):423-8. Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, Andersen JW, Swindells S, Sanne IM, Havlir DV, Kumwenda J. PMID: 24226057.
      View in: PubMed   Mentions:
    33. Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239. . 2014 Mar 01; 65(3):345-9. Marks KM, Kitch D, Chung RT, Hadigan C, Andersen J, Tien P, Luetkemeyer A, Alston-Smith B, Glesby MJ. PMID: 24525470.
      View in: PubMed   Mentions:
    34. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol. 2014 Apr; 52(4):1052-9. Luetkemeyer AF, Kendall MA, Wu X, Lourenço MC, Jentsch U, Swindells S, Qasba SS, Sanchez J, Havlir DV, Grinsztejn B, Sanne IM, Firnhaber C. PMID: 24430455.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    35. Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV Clin Trials. 2013 Nov-Dec; 14(6):274-83. Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG. PMID: 24334180.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    36. Household ventilation and tuberculosis transmission in Kampala, Uganda. Int J Tuberc Lung Dis. 2013 Jun; 17(6):764-70. Chamie G, Wandera B, Luetkemeyer A, Bogere J, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 23676159.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    37. Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. Clin Infect Dis. 2013 Aug; 57(4):586-93. Luetkemeyer AF, Rosenkranz SL, Lu D, Marzan F, Ive P, Hogg E, Swindells S, Benson CA, Grinsztejn B, Sanne IM, Havlir DV, Aweeka F. PMID: 23592830.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    38. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy. Top Antivir Med. 2013 Apr-May; 21(2):62-74. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 23681961.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2012 Jun-Jul; 20(2):48-60. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 22710907.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. . 2011 Nov 01; 58(3):e96-9. Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG. PMID: 22005002.
      View in: PubMed   Mentions:
    41. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011 Oct 20; 365(16):1482-91. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney JF, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I. PMID: 22010914.
      View in: PubMed   Mentions: 221     Fields:    Translation:HumansCells
    42. CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med. 2011 Oct 15; 184(8):972-9. Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PP, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W. PMID: 21737585.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    43. Tuberculosis drug development: ensuring people living with HIV are not left behind. Am J Respir Crit Care Med. 2011 Nov 15; 184(10):1107-13. Luetkemeyer AF, Getahun H, Chamie G, Lienhardt C, Havlir DV. PMID: 21868507.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2011 May-Jun; 19(2):58-68. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 21868823.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis. 2010 Oct; 14(10):1295-302. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 20843421.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    46. Current issues in the diagnosis and management of tuberculosis and HIV coinfection in the United States. Top HIV Med. 2010 Oct-Nov; 18(4):143-8. Luetkemeyer AF. PMID: 21107014.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    47. Tuberculosis as part of the natural history of HIV infection in developing countries. Clin Infect Dis. 2010 May 15; 50 Suppl 3:S245-54. Chamie G, Luetkemeyer A, Charlebois E, Havlir DV. PMID: 20397955.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    48. Complications of HIV disease and antiretroviral treatment. Top HIV Med. 2010 Apr-May; 18(2):57-65. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 20516525.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007 Apr 01; 175(7):737-42. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. PMID: 17218620.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    50. Antiretroviral therapy and TB. Trop Doct. 2006 Apr; 36(2):73-9. Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, Havlir DV. PMID: 16611437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. . 2006 Jan 01; 41(1):31-6. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. PMID: 16340470.
      View in: PubMed   Mentions:
    52. Willing and able? Provision of medication for abortion by future internists. Womens Health Issues. 2005 Jan-Feb; 15(1):39-44. Schwarz EB, Luetkemeyer A, Foster DG, Weitz TA, Lindes D, Stewart FH. PMID: 15661586.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Annie's Networks
    Concepts (213)
    Derived automatically from this person's publications.
    _
    Co-Authors (27)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _